Hero image with Pittsburgh background pittplusme.org/study/1017

Pitt+Me COMET Study


STUDY BASICS

Are you a woman age 40 or up who has been newly diagnosed (past 3 months) with non-invasive ductal carcinoma in situ (DCIS)? If so, you may be eligible for a study to help researchers evaluate the risks and benefits of usual treatment approach for DCIS vs. close monitoring approach. Study participation will last at least 5 years.


IRB:
  STUDY19030152 - HCC 16-207, Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial for Low Risk DCIS: A Phase III Prospective Randomized Trial

Age Range
AGE:   40 and Up

Duration DURATION:  At least 5 years

Location LOCATION: 
Magee-Women’s Hospital of UPMC
Compensation COMPENSATION: 
No
Phone Number PHONE NUMBER:
1-866-438-8230
I'M INTERESTED
SHARE STUDY
Printer Printer   Email A FriendEmail A Friend   FacebookFacebook   TwitterTwitter   Linked-InLinked-In
Search Icon pittplusme.org/study/1017
OR
Phone Number PHONE NUMBER:
1-866-438-8230

PittPlusMe.org 1-866-438-8230 PittPlusMe@pitt.edu
@PittPlusMe facebook twitter

Pitt+Me

This website is maintained by the Clinical and Translational Science Institute.
© Copyright 2018, University of Pittsburgh. All rights reserved.